data_5lah_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5lah _Structure_validation_residue.Date_analyzed 2017-05-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.534 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.81 155.26 61.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.703 0.764 . . . . 0.0 110.935 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 54.0 Cg_endo -69.8 83.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.36 13.83 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 16.1 mt-30 -75.51 156.15 85.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 0.0 110.917 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.9 Cg_endo -69.78 91.65 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.238 . . . . 0.0 112.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.77 -28.11 3.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.2 t -96.1 168.7 10.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.706 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 179.05 -178.95 48.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.508 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -69.03 120.09 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.355 . . . . 0.0 110.913 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 22.6 p -64.43 168.0 6.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 78.0 p -155.37 150.97 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.66 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -41.64 146.43 0.58 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 13.9 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.335 -0.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.66 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 2.2 m-20 -83.77 145.03 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 26.4 p90 -142.69 -177.92 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.35 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 tp10 -146.14 100.76 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.7 0.8 88.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.2 -81.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.34 142.48 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.55 146.63 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -64.33 171.2 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 35.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -148.96 -6.42 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.504 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 2.5 m-85 -123.01 179.26 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.6 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 4.1 p-80 -135.3 134.02 39.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.7 115.49 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 6.3 p -123.82 24.38 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -58.11 -9.09 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -46.53 -69.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 110.888 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 3.5 p-10 -107.29 29.06 7.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 25.8 m80 -147.94 123.55 10.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -119.78 168.99 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.475 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.7 m -104.49 170.21 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -46.92 -39.27 11.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.76 122.54 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.4 p -58.87 78.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.08 -22.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 1.1 m-20 -89.64 132.85 34.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.57 132.28 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.33 129.03 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 70.1 m -97.22 159.95 14.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 60.4 m -135.55 131.15 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 31' ' ' SER . 22.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.58 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.16 157.99 62.27 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.68 0.753 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.79 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.332 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.28 2.36 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 55.3 mt-30 -75.17 155.25 86.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.527 0.68 . . . . 0.0 110.972 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 81.64 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.73 2.287 . . . . 0.0 112.357 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.95 -29.6 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.11 157.31 15.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.719 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -179.85 -176.25 47.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -68.65 123.66 21.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.5 p -64.34 163.3 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 32.1 t -152.9 149.19 28.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 23.6 mmt180 -41.07 145.9 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.589 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 54.2 Cg_endo -69.71 12.92 1.57 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.385 -0.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.634 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -84.99 145.21 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.403 ' HE2' ' CD1' ' A' ' 26' ' ' PHE . 28.7 p90 -143.34 -178.06 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.959 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.82 135.96 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 tp10 -146.51 103.07 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.41 15.34 63.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.26 -77.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.773 0.32 . . . . 0.0 111.137 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 142.67 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 35.2 m -63.36 160.15 16.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 25' ' ' GLY . 11.4 mt-10 -75.6 171.25 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.23 38.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -164.86 14.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 3.8 m-85 -134.73 178.16 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 2.7 p-80 -137.46 129.53 29.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.3 t70 -58.9 115.11 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 5.9 p -118.62 25.22 10.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.45 -13.71 2.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.534 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 31.1 p -43.64 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -106.82 31.03 5.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 31.6 m170 -146.28 116.51 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.719 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -116.89 164.79 14.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 11.4 m -101.56 173.65 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.16 -39.1 27.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.51 120.73 34.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.07 -23.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -87.07 130.99 34.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 128.79 41.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.27 132.44 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 60.1 m -97.09 160.73 14.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.592 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 65.7 m -136.04 130.51 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.53 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.69 155.84 61.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 0.0 110.938 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.8 Cg_endo -69.71 82.9 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.742 2.295 . . . . 0.0 112.342 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.5 13.09 2.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.0 mt-30 -75.67 156.05 85.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 54.1 Cg_endo -69.73 91.15 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.51 -28.52 3.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.741 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.9 t -96.07 170.27 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.701 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.09 -179.53 47.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.39 120.48 14.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.816 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.7 p -64.16 166.51 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -154.93 149.6 26.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.654 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER -41.46 146.39 0.55 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.615 0.722 . . . . 0.0 110.844 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.58 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 53.2 Cg_endo -69.79 13.72 1.48 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.638 -1.818 . . . . 0.0 112.346 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.654 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 m-20 -83.95 145.61 28.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 25.3 p90 -143.35 -177.15 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 m -87.65 135.91 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.13 101.99 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.05 9.47 77.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.64 -74.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.9 142.47 12.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 28.7 m -60.82 144.23 53.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.68 164.53 24.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.57 88.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.82 -30.04 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 23.2 m-85 -96.03 168.55 10.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 4.7 p-80 -130.04 139.26 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.4 t70 -65.27 113.42 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 3.8 p -120.15 26.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.99 -10.79 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -43.8 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -108.04 31.83 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 25.0 m80 -148.3 120.14 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.741 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.55 169.83 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.498 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 11.2 m -106.49 -178.17 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -44.75 -44.16 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 39' ' ' GLY . . . -98.52 143.87 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -71.72 44.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 37' ' ' ALA . . . -149.75 -20.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -92.15 129.33 38.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 131.77 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.15 129.95 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 52.4 m -95.62 160.79 14.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 62.2 m -136.07 130.95 34.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.6 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.56 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.91 159.27 57.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.689 0.757 . . . . 0.0 110.964 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.77 79.79 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.66 2.24 . . . . 0.0 112.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.05 0.75 2.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 47.4 mt-30 -75.56 155.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.17 5.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.72 2.28 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 104.55 2.67 43.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.0 t -134.59 154.65 51.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.812 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.726 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -165.99 -178.63 38.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -68.75 119.8 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 19.1 p -64.21 167.34 6.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -155.08 149.89 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 57.8 mtt85 -41.39 146.31 0.55 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.596 0.712 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 54.3 Cg_endo -69.75 13.51 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.14 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.329 0.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.657 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.5 m-20 -84.16 144.36 29.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 21.1 p90 -143.3 -177.19 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.2 132.65 33.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -147.76 116.6 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.47 -20.27 72.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -128.54 -158.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.738 0.304 . . . . 0.0 111.113 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.8 129.45 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 4.8 m -53.99 161.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.9 mt-10 -73.68 160.66 31.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -56.82 82.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 162.4 -37.6 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 2.0 m-85 -95.97 179.54 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.2 p-80 -137.71 131.42 31.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 10.7 t0 -60.47 114.25 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 2.9 p -118.86 24.93 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.11 -11.54 3.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.447 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 47.6 t -44.85 -71.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 1.3 p30 -108.31 30.46 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.593 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 27.5 m80 -148.26 121.36 8.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.726 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.0 170.67 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.48 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.5 m -106.04 171.67 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -48.09 -39.84 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.99 124.3 37.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 p -59.59 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.43 -22.14 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -90.07 132.14 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.33 131.86 40.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.33 128.55 33.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 30.2 m -94.98 161.57 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 65.3 m -136.2 130.19 32.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.9 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.56 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.49 157.9 60.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.674 0.75 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.76 84.27 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.76 11.94 3.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.518 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 18.3 mt-30 -75.93 155.12 84.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 84.53 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 135.26 3.05 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.3 t -134.45 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.723 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -164.81 -177.45 37.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -68.32 121.26 15.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.4 p -64.34 161.61 16.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -149.3 147.65 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.649 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 7.5 mtt180 -39.89 145.84 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.651 0.738 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.602 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 53.9 Cg_endo -69.72 13.77 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.314 -0.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.649 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -83.93 144.24 29.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.3 p90 -142.99 -172.31 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -92.42 135.14 34.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -146.46 104.15 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.45 78.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.427 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.56 -72.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.4 144.16 9.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 57.0 m -55.94 142.35 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.92 165.27 23.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.67 91.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.22 -24.04 3.12 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 62.2 m-85 -94.76 163.82 13.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.2 p-80 -127.46 141.97 51.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 t70 -64.94 114.96 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 19.1 p -126.73 22.22 6.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -57.89 -9.57 5.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -46.16 -67.09 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 3.4 p30 -108.52 28.07 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 24.7 m80 -147.9 121.18 8.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.723 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.68 168.23 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 7.8 m -103.85 168.11 9.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.97 -39.58 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.8 122.34 36.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 p -58.65 78.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.94 -22.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.2 m-20 -89.69 132.19 35.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.9 134.7 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 m -80.44 128.55 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.3 m -102.69 136.6 42.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.589 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 37.1 m -111.71 134.43 53.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.824 0.345 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.557 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -85.01 158.61 58.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.671 0.748 . . . . 0.0 110.922 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.557 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.67 81.05 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.282 . . . . 0.0 112.358 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 2.06 2.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 43.7 mt-30 -75.98 155.2 84.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 118.67 5.82 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 102.73 3.18 49.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.3 t -134.16 155.55 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.73 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -168.28 -177.59 39.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -68.66 121.38 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 18.9 p -64.15 165.39 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 2.9 t -154.43 149.27 26.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.645 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 3.1 mtt180 -40.95 146.04 0.51 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.596 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 53.7 Cg_endo -69.77 13.41 1.52 Allowed 'Cis proline' 0 C--N 1.342 0.2 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.339 -0.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.645 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.4 m-20 -84.15 145.7 28.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.424 ' HE1' ' CD2' ' A' ' 26' ' ' PHE . 26.9 p90 -143.29 -177.12 5.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.3 136.39 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.871 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 tp10 -146.12 102.43 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.21 6.67 81.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.69 -76.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 111.127 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -158.14 144.5 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 25.8 m -65.02 158.81 24.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 mm-40 -75.76 171.8 13.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.39 39.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -162.08 10.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.463 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.59 ' CE2' ' HB1' ' A' ' 45' ' ' ALA . 3.6 m-85 -134.53 178.91 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.6 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 2.7 p-80 -138.02 129.29 27.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.84 115.02 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 4.5 p -119.0 23.45 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.04 -12.36 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -44.87 -70.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.9 m80 -148.08 120.63 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.73 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -117.99 169.27 9.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.485 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 11.9 m -106.0 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 -39.64 8.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.68 121.39 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -58.05 78.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.75 -22.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 3.9 m-20 -88.82 131.05 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 130.54 40.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.38 131.91 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 61.3 m -96.11 161.4 13.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 73.7 m -136.56 129.8 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.537 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.87 155.04 61.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.658 0.742 . . . . 0.0 110.922 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.537 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.72 81.06 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 0.0 112.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.67 13.19 2.08 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.491 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 19.0 mt-30 -75.59 156.07 85.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.615 0.721 . . . . 0.0 110.877 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 90.57 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.646 2.231 . . . . 0.0 112.39 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.78 -28.33 3.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 6.0 t -95.63 170.75 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.701 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 175.88 -179.11 47.2 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -67.75 121.79 16.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.6 p -64.19 163.89 11.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.853 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 99.4 p -152.54 147.42 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.646 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 12.7 mmt-85 -39.76 145.57 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.632 0.73 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.603 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 52.9 Cg_endo -69.82 13.68 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.688 -1.796 . . . . 0.0 112.285 0.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.646 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.21 145.05 28.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 22.2 p90 -143.32 -174.69 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.08 136.81 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 tp10 -146.88 114.84 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' CA ' ' OD1' ' A' ' 40' ' ' ASP . . . -101.03 6.11 56.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.518 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.63 -72.64 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.332 . . . . 0.0 111.087 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 145.91 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 60.3 m -57.02 143.86 36.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.56 165.69 22.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -57.53 92.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.5 -21.46 4.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 59.4 m-85 -95.02 162.79 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.7 p-80 -127.24 141.04 51.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.7 t0 -65.43 113.93 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 7.3 p -121.81 24.55 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.08 -11.83 3.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.475 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.486 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 1.7 m -43.88 -71.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.572 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.5 OUTLIER -110.37 32.07 5.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 26.1 m80 -148.43 118.07 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.88 169.97 9.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.475 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.6 m -104.79 170.07 8.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.65 -38.96 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.67 123.84 37.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -59.62 77.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.06 -22.33 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.523 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.475 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.2 129.69 36.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CD ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.51 133.61 37.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.0 m -79.74 130.14 35.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.0 m -103.46 136.13 43.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 39.5 m -110.79 134.24 52.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.603 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 5.0 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.467 ' HB2' ' CG ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -88.14 163.22 38.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.691 0.757 . . . . 0.0 110.906 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.471 ' HA ' ' CE2' ' A' ' 34' ' ' TRP . 53.9 Cg_endo -69.79 102.64 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.36 17.99 16.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.467 ' CG ' ' HB2' ' A' ' 2' ' ' TYR . 9.4 mt-30 -75.62 158.57 82.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.7 Cg_endo -69.76 90.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 0.0 112.304 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.83 -25.8 5.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 5.4 t -95.55 169.47 10.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.706 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.06 -179.18 48.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.48 121.43 15.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.7 p -64.33 163.8 12.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -150.82 146.75 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.656 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 6.9 mtp-105 -39.82 146.04 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.594 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 54.1 Cg_endo -69.75 13.98 1.42 Allowed 'Cis proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.319 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.656 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.14 144.32 29.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.2 p90 -143.51 -173.18 3.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.49 135.53 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -146.81 105.76 3.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.88 4.77 75.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.445 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.8 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.73 142.87 9.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 32.9 m -56.57 144.33 32.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.696 ' CG ' ' CD2' ' A' ' 26' ' ' PHE . 3.4 pt-20 -69.26 158.54 34.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.81 81.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 155.04 -24.94 0.61 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.696 ' CD2' ' CG ' ' A' ' 23' ' ' GLU . 3.1 m-85 -96.65 178.7 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.3 p-80 -137.48 134.25 35.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 7.7 t0 -62.41 116.65 5.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.3 p -122.23 27.27 8.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.83 -13.29 4.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.46 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -110.46 33.18 4.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 26.7 m80 -148.62 117.27 6.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.757 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -118.83 171.87 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.4 m -105.31 169.77 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.45 -39.44 22.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.92 122.65 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -58.27 78.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.41 -22.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.46 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -90.91 131.57 36.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 134.12 38.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.6 m -80.12 128.6 33.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 21.5 m -102.11 135.31 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.592 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 47.4 m -109.97 133.43 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.54 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -84.63 154.86 62.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.618 0.723 . . . . 0.0 110.934 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.7 80.8 0.84 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.59 13.83 2.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.497 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.3 mt-30 -75.63 156.13 85.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.3 Cg_endo -69.79 91.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.06 -28.0 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.4 t -95.75 169.48 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.695 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.04 -179.39 47.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -68.35 121.86 17.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.8 p -63.91 168.26 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 35.8 t -153.99 147.36 24.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.668 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.7 mmt-85 -39.88 146.31 0.4 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.598 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 14.11 1.41 Allowed 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.346 0.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.668 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -85.0 143.85 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.858 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 18.8 p90 -143.31 -173.67 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.596 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.45 131.84 35.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.2 tp10 -147.06 116.04 6.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.59 -16.54 75.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.452 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -127.64 -160.92 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -64.29 130.97 45.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.7 m -54.17 159.8 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 mt-10 -72.63 158.87 34.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -56.58 80.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 161.32 -32.85 0.37 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 45' ' ' ALA . 2.4 m-85 -95.69 178.37 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.7 p-80 -137.22 130.44 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.1 t0 -61.84 114.23 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.6 p -118.09 27.38 9.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.88 -13.87 3.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 35.7 p -42.19 -74.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 1.3 p-10 -110.05 32.96 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 27.6 m80 -148.2 116.69 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.748 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -117.65 172.27 7.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.2 m -105.77 170.98 7.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.65 -39.5 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.17 123.37 37.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 p -58.89 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.55 -22.64 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.441 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.92 132.73 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.06 133.13 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 m -80.4 126.85 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.0 m -99.48 136.23 39.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.605 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 49.6 m -109.89 132.23 54.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.598 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' SER . 24.1 p . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.58 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.27 158.16 62.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.753 0.787 . . . . 0.0 110.898 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.69 79.31 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.31 2.59 2.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.499 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 54.9 mt-30 -75.29 155.49 85.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.398 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.57 1.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.626 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.1 158.54 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.14 -176.32 47.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -69.08 122.28 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.367 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.9 p -63.54 166.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 33.8 m -151.98 147.58 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.665 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -39.68 146.24 0.39 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.6 ' HB2' ' CB ' ' A' ' 45' ' ' ALA . 54.0 Cg_endo -69.77 14.09 1.42 Allowed 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.38 -0.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.665 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -85.18 143.94 28.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 17.9 p90 -143.5 -173.83 4.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.43 131.36 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -146.75 116.01 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.51 -13.15 80.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -130.57 -160.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -64.35 130.26 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.826 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.4 m -54.61 159.81 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -71.98 157.91 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -55.6 82.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 158.19 -32.96 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 45' ' ' ALA . 2.3 m-85 -95.12 177.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.5 p-80 -136.67 131.16 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 2.1 t70 -63.01 110.9 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.1 p -114.02 26.3 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.43 -13.81 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 21.4 m -43.11 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.5 OUTLIER -107.81 31.37 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 29.5 m80 -146.94 116.42 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -117.65 166.59 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 10.3 m -101.23 173.15 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -39.55 51.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.03 122.76 36.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.4 m -58.42 79.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.31 -22.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 12.9 m-20 -89.94 131.21 35.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.85 132.74 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 m -79.59 127.39 32.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.6 m -101.14 134.43 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.603 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 50.2 m -108.82 132.54 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.6 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.55 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.81 155.26 61.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.703 0.764 . . . . 0.0 110.935 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.55 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 54.0 Cg_endo -69.8 83.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.36 13.83 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 16.1 mt-30 -75.51 156.15 85.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 0.0 110.917 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.9 Cg_endo -69.78 91.65 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.238 . . . . 0.0 112.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.77 -28.11 3.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.2 t -96.1 168.7 10.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.703 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 179.05 -178.95 48.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.508 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -69.03 120.09 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.355 . . . . 0.0 110.913 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 22.6 p -64.43 168.0 6.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 78.0 p -155.37 150.97 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.667 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -41.64 146.43 0.58 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.001 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 13.9 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.335 -0.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 2.2 m-20 -83.77 145.03 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 26.4 p90 -142.69 -177.92 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.35 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 tp10 -146.14 100.76 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.7 0.8 88.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.2 -81.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.34 142.48 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.55 146.63 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -64.33 171.2 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 35.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -148.96 -6.42 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.504 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.806 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.5 m-85 -123.01 179.26 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 5.7 p80 -135.3 134.02 39.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.7 115.49 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 6.3 p -123.82 24.38 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -58.11 -9.09 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -46.53 -69.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 110.888 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 3.5 p-10 -107.29 29.06 7.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 25.8 m80 -147.94 123.55 10.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -119.78 168.99 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.7 m -104.49 170.21 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -46.92 -39.27 11.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.76 122.54 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.4 p -58.87 78.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.08 -22.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 1.1 m-20 -89.64 132.85 34.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -94.57 132.28 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.33 129.03 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 70.1 m -97.22 159.95 14.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.588 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 60.4 m -135.55 131.15 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 31' ' ' SER . 22.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.16 157.99 62.27 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.68 0.753 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.79 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.332 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.28 2.36 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 55.3 mt-30 -75.17 155.25 86.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.527 0.68 . . . . 0.0 110.972 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 81.64 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.73 2.287 . . . . 0.0 112.357 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.95 -29.6 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.11 157.31 15.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.717 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -179.85 -176.25 47.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -68.65 123.66 21.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.5 p -64.34 163.3 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 32.1 t -152.9 149.19 28.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.642 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 23.6 mmt180 -41.07 145.9 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.996 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.2 Cg_endo -69.71 12.92 1.57 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.385 -0.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.642 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -84.99 145.21 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 26' ' ' PHE . 28.7 p90 -143.34 -178.06 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.959 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.82 135.96 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 tp10 -146.51 103.07 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.41 15.34 63.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.26 -77.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.773 0.32 . . . . 0.0 111.137 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 142.67 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 35.2 m -63.36 160.15 16.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 25' ' ' GLY . 11.4 mt-10 -75.6 171.25 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.23 38.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -164.86 14.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.866 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 3.8 m-85 -134.73 178.16 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 2.5 p80 -137.46 129.53 29.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.3 t70 -58.9 115.11 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 5.9 p -118.62 25.22 10.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.45 -13.71 2.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.534 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 31.1 p -43.64 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -106.82 31.03 5.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 31.6 m170 -146.28 116.51 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.717 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -116.89 164.79 14.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 11.4 m -101.56 173.65 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.16 -39.1 27.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.51 120.73 34.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.07 -23.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -87.07 130.99 34.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 128.79 41.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.27 132.44 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 60.1 m -97.09 160.73 14.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.559 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 65.7 m -136.04 130.51 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.996 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.69 155.84 61.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 0.0 110.938 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.8 Cg_endo -69.71 82.9 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.742 2.295 . . . . 0.0 112.342 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.5 13.09 2.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.0 mt-30 -75.67 156.05 85.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 91.15 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.51 -28.52 3.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.741 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.9 t -96.07 170.27 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.699 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.09 -179.53 47.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.39 120.48 14.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.816 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.7 p -64.16 166.51 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -154.93 149.6 26.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER -41.46 146.39 0.55 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.615 0.722 . . . . 0.0 110.844 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.004 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.2 Cg_endo -69.79 13.72 1.48 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.638 -1.818 . . . . 0.0 112.346 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.662 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 m-20 -83.95 145.61 28.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 25.3 p90 -143.35 -177.15 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 m -87.65 135.91 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.13 101.99 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.05 9.47 77.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.64 -74.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.9 142.47 12.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 28.7 m -60.82 144.23 53.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.68 164.53 24.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.57 88.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.82 -30.04 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 23.2 m-85 -96.03 168.55 10.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.615 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 5.3 p80 -130.04 139.26 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.4 t70 -65.27 113.42 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 3.8 p -120.15 26.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.99 -10.79 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -43.8 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -108.04 31.83 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 61.5 m-70 -148.3 120.14 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.741 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.55 169.83 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 11.2 m -106.49 -178.17 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -44.75 -44.16 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 39' ' ' GLY . . . -98.52 143.87 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -71.72 44.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' ALA . . . -149.75 -20.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -92.15 129.33 38.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 131.77 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.15 129.95 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 52.4 m -95.62 160.79 14.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.615 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 62.2 m -136.07 130.95 34.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.004 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.6 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.58 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.91 159.27 57.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.689 0.757 . . . . 0.0 110.964 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.77 79.79 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.66 2.24 . . . . 0.0 112.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.05 0.75 2.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 47.4 mt-30 -75.56 155.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.17 5.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.72 2.28 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 104.55 2.67 43.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.0 t -134.59 154.65 51.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.812 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.724 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -165.99 -178.63 38.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -68.75 119.8 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 19.1 p -64.21 167.34 6.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -155.08 149.89 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.666 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 57.8 mtt85 -41.39 146.31 0.55 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.596 0.712 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.997 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.3 Cg_endo -69.75 13.51 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.14 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.329 0.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.666 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.5 m-20 -84.16 144.36 29.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 21.1 p90 -143.3 -177.19 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.2 132.65 33.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -147.76 116.6 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.47 -20.27 72.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -128.54 -158.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.738 0.304 . . . . 0.0 111.113 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.8 129.45 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 4.8 m -53.99 161.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.9 mt-10 -73.68 160.66 31.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -56.82 82.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 162.4 -37.6 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -95.97 179.54 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 3.0 p80 -137.71 131.42 31.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 10.7 t0 -60.47 114.25 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 2.9 p -118.86 24.93 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.11 -11.54 3.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.447 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 47.6 t -44.85 -71.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.3 p30 -108.31 30.46 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 71.0 m-70 -148.26 121.36 8.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.724 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.0 170.67 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.5 m -106.04 171.67 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -48.09 -39.84 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.99 124.3 37.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 p -59.59 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.43 -22.14 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -90.07 132.14 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.33 131.86 40.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.33 128.55 33.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 30.2 m -94.98 161.57 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.565 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 65.3 m -136.2 130.19 32.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.9 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.575 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.49 157.9 60.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.674 0.75 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.76 84.27 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.76 11.94 3.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 18.3 mt-30 -75.93 155.12 84.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 84.53 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 135.26 3.05 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.3 t -134.45 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.721 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -164.81 -177.45 37.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -68.32 121.26 15.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.4 p -64.34 161.61 16.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -149.3 147.65 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 7.5 mtt180 -39.89 145.84 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.651 0.738 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.024 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.9 Cg_endo -69.72 13.77 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.314 -0.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.657 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -83.93 144.24 29.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.3 p90 -142.99 -172.31 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -92.42 135.14 34.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -146.46 104.15 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.45 78.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.427 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.56 -72.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.4 144.16 9.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 57.0 m -55.94 142.35 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.92 165.27 23.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.67 91.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.22 -24.04 3.12 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.854 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 62.2 m-85 -94.76 163.82 13.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 3.9 p80 -127.46 141.97 51.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 t70 -64.94 114.96 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 19.1 p -126.73 22.22 6.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -57.89 -9.57 5.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -46.16 -67.09 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.4 p30 -108.52 28.07 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 60.7 m-70 -147.9 121.18 8.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.721 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.68 168.23 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 7.8 m -103.85 168.11 9.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.97 -39.58 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.8 122.34 36.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 p -58.65 78.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.94 -22.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.2 m-20 -89.69 132.19 35.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.9 134.7 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 m -80.44 128.55 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.3 m -102.69 136.6 42.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.574 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 37.1 m -111.71 134.43 53.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.824 0.345 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.576 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -85.01 158.61 58.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.671 0.748 . . . . 0.0 110.922 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.67 81.05 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.282 . . . . 0.0 112.358 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 2.06 2.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 43.7 mt-30 -75.98 155.2 84.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 118.67 5.82 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 102.73 3.18 49.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.3 t -134.16 155.55 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.729 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -168.28 -177.59 39.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -68.66 121.38 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 18.9 p -64.15 165.39 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 2.9 t -154.43 149.27 26.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.654 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 3.1 mtt180 -40.95 146.04 0.51 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.997 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.7 Cg_endo -69.77 13.41 1.52 Allowed 'Cis proline' 0 C--N 1.342 0.2 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.339 -0.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.654 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.4 m-20 -84.15 145.7 28.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HE1' ' CD2' ' A' ' 26' ' ' PHE . 26.9 p90 -143.29 -177.12 5.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.3 136.39 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.871 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 tp10 -146.12 102.43 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.21 6.67 81.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.69 -76.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 111.127 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -158.14 144.5 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 25.8 m -65.02 158.81 24.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 mm-40 -75.76 171.8 13.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.39 39.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -162.08 10.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.463 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.883 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 3.6 m-85 -134.53 178.91 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.568 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 2.5 p80 -138.02 129.29 27.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.84 115.02 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 4.5 p -119.0 23.45 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.04 -12.36 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -44.87 -70.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 72.9 m-70 -148.08 120.63 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.729 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -117.99 169.27 9.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 11.9 m -106.0 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 -39.64 8.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.68 121.39 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -58.05 78.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.75 -22.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 3.9 m-20 -88.82 131.05 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 130.54 40.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.38 131.91 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 61.3 m -96.11 161.4 13.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.568 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 73.7 m -136.56 129.8 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.559 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.87 155.04 61.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.658 0.742 . . . . 0.0 110.922 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.72 81.06 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 0.0 112.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.67 13.19 2.08 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 19.0 mt-30 -75.59 156.07 85.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.615 0.721 . . . . 0.0 110.877 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 90.57 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.646 2.231 . . . . 0.0 112.39 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.78 -28.33 3.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 6.0 t -95.63 170.75 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.698 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 175.88 -179.11 47.2 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.46 ' O ' ' CG ' ' A' ' 10' ' ' HIS . 3.5 p-80 -67.75 121.79 16.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.6 p -64.19 163.89 11.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.853 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 99.4 p -152.54 147.42 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.656 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 12.7 mmt-85 -39.76 145.57 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.632 0.73 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 52.9 Cg_endo -69.82 13.68 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.688 -1.796 . . . . 0.0 112.285 0.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.656 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.21 145.05 28.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 22.2 p90 -143.32 -174.69 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.08 136.81 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 tp10 -146.88 114.84 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' CA ' ' OD1' ' A' ' 40' ' ' ASP . . . -101.03 6.11 56.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.518 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.63 -72.64 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.332 . . . . 0.0 111.087 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 145.91 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 60.3 m -57.02 143.86 36.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.56 165.69 22.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -57.53 92.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.5 -21.46 4.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.848 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 59.4 m-85 -95.02 162.79 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.548 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 4.7 p80 -127.24 141.04 51.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.7 t0 -65.43 113.93 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 7.3 p -121.81 24.55 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.08 -11.83 3.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.475 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.486 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 1.7 m -43.88 -71.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -110.37 32.07 5.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 57.4 m-70 -148.43 118.07 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.88 169.97 9.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.6 m -104.79 170.07 8.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.65 -38.96 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.67 123.84 37.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -59.62 77.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.06 -22.33 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.523 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.2 129.69 36.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CD ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.51 133.61 37.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.0 m -79.74 130.14 35.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.0 m -103.46 136.13 43.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 39.5 m -110.79 134.24 52.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 5.0 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.489 ' HB2' ' CG ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -88.14 163.22 38.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.691 0.757 . . . . 0.0 110.906 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 34' ' ' TRP . 53.9 Cg_endo -69.79 102.64 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.36 17.99 16.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.489 ' CG ' ' HB2' ' A' ' 2' ' ' TYR . 9.4 mt-30 -75.62 158.57 82.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.7 Cg_endo -69.76 90.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 0.0 112.304 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.83 -25.8 5.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 5.4 t -95.55 169.47 10.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.704 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.06 -179.18 48.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.48 121.43 15.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.7 p -64.33 163.8 12.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -150.82 146.75 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.664 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 6.9 mtp-105 -39.82 146.04 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.048 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.1 Cg_endo -69.75 13.98 1.42 Allowed 'Cis proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.319 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.664 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.14 144.32 29.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.2 p90 -143.51 -173.18 3.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.49 135.53 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -146.81 105.76 3.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.88 4.77 75.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.445 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.8 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.73 142.87 9.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 32.9 m -56.57 144.33 32.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.696 ' CG ' ' CD2' ' A' ' 26' ' ' PHE . 3.4 pt-20 -69.26 158.54 34.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.81 81.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 155.04 -24.94 0.61 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 3.1 m-85 -96.65 178.7 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 4.0 p80 -137.48 134.25 35.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 7.7 t0 -62.41 116.65 5.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.3 p -122.23 27.27 8.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.83 -13.29 4.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.46 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -110.46 33.18 4.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 26.7 m80 -148.62 117.27 6.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.757 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -118.83 171.87 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.4 m -105.31 169.77 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.45 -39.44 22.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.92 122.65 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -58.27 78.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.41 -22.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.46 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -90.91 131.57 36.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 134.12 38.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.6 m -80.12 128.6 33.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 21.5 m -102.11 135.31 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.53 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 47.4 m -109.97 133.43 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.048 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.556 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -84.63 154.86 62.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.618 0.723 . . . . 0.0 110.934 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.7 80.8 0.84 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.59 13.83 2.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.3 mt-30 -75.63 156.13 85.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.3 Cg_endo -69.79 91.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.06 -28.0 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.4 t -95.75 169.48 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.692 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.04 -179.39 47.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -68.35 121.86 17.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.8 p -63.91 168.26 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 35.8 t -153.99 147.36 24.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.677 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.7 mmt-85 -39.88 146.31 0.4 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.081 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 14.11 1.41 Allowed 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.346 0.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -85.0 143.85 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.858 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 18.8 p90 -143.31 -173.67 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.596 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.45 131.84 35.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.2 tp10 -147.06 116.04 6.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.59 -16.54 75.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.452 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -127.64 -160.92 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -64.29 130.97 45.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.7 m -54.17 159.8 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 mt-10 -72.63 158.87 34.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -56.58 80.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 161.32 -32.85 0.37 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 2.4 m-85 -95.69 178.37 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 4.2 p80 -137.22 130.44 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.1 t0 -61.84 114.23 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.6 p -118.09 27.38 9.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.88 -13.87 3.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 35.7 p -42.19 -74.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 1.3 p-10 -110.05 32.96 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 27.6 m80 -148.2 116.69 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.748 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -117.65 172.27 7.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.2 m -105.77 170.98 7.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.65 -39.5 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.17 123.37 37.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 p -58.89 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.55 -22.64 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.441 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.92 132.73 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.06 133.13 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 m -80.4 126.85 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.0 m -99.48 136.23 39.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.55 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 49.6 m -109.89 132.23 54.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.081 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' SER . 24.1 p . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.599 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.27 158.16 62.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.753 0.787 . . . . 0.0 110.898 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.69 79.31 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.31 2.59 2.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 54.9 mt-30 -75.29 155.49 85.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.398 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.57 1.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.626 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.1 158.54 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.14 -176.32 47.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -69.08 122.28 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.367 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.9 p -63.54 166.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 33.8 m -151.98 147.58 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.672 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -39.68 146.24 0.39 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.083 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.0 Cg_endo -69.77 14.09 1.42 Allowed 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.38 -0.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.672 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -85.18 143.94 28.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 17.9 p90 -143.5 -173.83 4.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.43 131.36 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -146.75 116.01 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.51 -13.15 80.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -130.57 -160.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -64.35 130.26 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.826 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.4 m -54.61 159.81 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -71.98 157.91 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -55.6 82.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 158.19 -32.96 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.3 m-85 -95.12 177.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.556 ' CE1' ' O ' ' A' ' 44' ' ' CYS . 3.5 p80 -136.67 131.16 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 2.1 t70 -63.01 110.9 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.1 p -114.02 26.3 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.43 -13.81 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 21.4 m -43.11 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.5 OUTLIER -107.81 31.37 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 29.5 m80 -146.94 116.42 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -117.65 166.59 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 10.3 m -101.23 173.15 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -39.55 51.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.03 122.76 36.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.4 m -58.42 79.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.31 -22.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 12.9 m-20 -89.94 131.21 35.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.85 132.74 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 m -79.59 127.39 32.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.6 m -101.14 134.43 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.556 ' O ' ' CE1' ' A' ' 27' ' ' HIS . 50.2 m -108.82 132.54 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 1.083 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.55 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.81 155.26 61.64 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.703 0.764 . . . . 0.0 110.935 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.55 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 54.0 Cg_endo -69.8 83.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.708 2.272 . . . . 0.0 112.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.36 13.83 2.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.466 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 16.1 mt-30 -75.51 156.15 85.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.569 0.7 . . . . 0.0 110.917 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.9 Cg_endo -69.78 91.65 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.238 . . . . 0.0 112.355 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.77 -28.11 3.78 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.2 t -96.1 168.7 10.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.851 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.703 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 179.05 -178.95 48.96 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.508 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -69.03 120.09 14.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.844 0.355 . . . . 0.0 110.913 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 22.6 p -64.43 168.0 6.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 78.0 p -155.37 150.97 27.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.667 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -41.64 146.43 0.58 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 110.873 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.001 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 13.9 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 -1.81 . . . . 0.0 112.335 -0.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.667 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 2.2 m-20 -83.77 145.03 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 26.4 p90 -142.69 -177.92 5.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.974 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.35 137.04 32.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.8 tp10 -146.14 100.76 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.7 0.8 88.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.473 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.2 -81.21 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.34 142.48 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.55 146.63 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 0.4 OUTLIER -64.33 171.2 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 35.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.853 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -148.96 -6.42 0.22 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.504 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.806 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.5 m-85 -123.01 179.26 4.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.6 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 4.1 p-80 -135.3 134.02 39.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.7 115.49 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 6.3 p -123.82 24.38 8.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -58.11 -9.09 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.442 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -46.53 -69.88 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.875 0.369 . . . . 0.0 110.888 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 3.5 p-10 -107.29 29.06 7.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 25.8 m80 -147.94 123.55 10.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.868 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -119.78 168.99 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.7 m -104.49 170.21 8.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -46.92 -39.27 11.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.76 122.54 36.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 89.4 p -58.87 78.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.849 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.08 -22.39 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 1.1 m-20 -89.64 132.85 34.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -94.57 132.28 39.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.33 129.03 34.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 70.1 m -97.22 159.95 14.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 60.4 m -135.55 131.15 35.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.001 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 31' ' ' SER . 22.0 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.597 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.16 157.99 62.27 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.68 0.753 . . . . 0.0 110.921 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.79 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 0.0 112.332 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.28 2.36 2.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 55.3 mt-30 -75.17 155.25 86.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.527 0.68 . . . . 0.0 110.972 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 81.64 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.73 2.287 . . . . 0.0 112.357 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.95 -29.6 1.68 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.449 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.11 157.31 15.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.717 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -179.85 -176.25 47.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.457 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -68.65 123.66 21.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.5 p -64.34 163.3 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 32.1 t -152.9 149.19 28.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.642 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 23.6 mmt180 -41.07 145.9 0.53 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.559 0.695 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.996 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.2 Cg_endo -69.71 12.92 1.57 Allowed 'Cis proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.385 -0.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.642 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -84.99 145.21 27.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' HE2' ' CD1' ' A' ' 26' ' ' PHE . 28.7 p90 -143.34 -178.06 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.959 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.82 135.96 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 2.0 tp10 -146.51 103.07 3.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.41 15.34 63.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.453 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -140.26 -77.52 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.773 0.32 . . . . 0.0 111.137 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.51 142.67 18.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 35.2 m -63.36 160.15 16.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 25' ' ' GLY . 11.4 mt-10 -75.6 171.25 14.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.23 38.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -164.86 14.12 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.449 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.866 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 3.8 m-85 -134.73 178.16 7.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.893 0.378 . . . . 0.0 110.87 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 2.7 p-80 -137.46 129.53 29.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.831 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.3 t70 -58.9 115.11 2.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 5.9 p -118.62 25.22 10.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.45 -13.71 2.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.534 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 31.1 p -43.64 -74.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.838 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.2 OUTLIER -106.82 31.03 5.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.875 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 31.6 m170 -146.28 116.51 7.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.717 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -116.89 164.79 14.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 11.4 m -101.56 173.65 6.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -49.16 -39.1 27.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.51 120.73 34.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.55 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.07 -23.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -87.07 130.99 34.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 110.853 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 128.79 41.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.27 132.44 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 60.1 m -97.09 160.73 14.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.592 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 65.7 m -136.04 130.51 33.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.924 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.996 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.474 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.865 0.364 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.546 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.69 155.84 61.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 0.0 110.938 -179.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.8 Cg_endo -69.71 82.9 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.742 2.295 . . . . 0.0 112.342 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.5 13.09 2.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.506 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.0 mt-30 -75.67 156.05 85.0 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 91.15 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.35 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.51 -28.52 3.41 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.741 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.9 t -96.07 170.27 9.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.885 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.699 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.09 -179.53 47.94 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.457 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.39 120.48 14.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 0.0 110.816 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.7 p -64.16 166.51 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -154.93 149.6 26.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER -41.46 146.39 0.55 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.615 0.722 . . . . 0.0 110.844 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.004 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.2 Cg_endo -69.79 13.72 1.48 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.638 -1.818 . . . . 0.0 112.346 -0.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.662 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.6 m-20 -83.95 145.61 28.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 17' ' ' CYS . 25.3 p90 -143.35 -177.15 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 1.3 m -87.65 135.91 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.849 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -146.13 101.99 3.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.05 9.47 77.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.486 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.64 -74.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.9 142.47 12.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 28.7 m -60.82 144.23 53.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.68 164.53 24.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.57 88.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.82 -30.04 1.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.472 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.795 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 23.2 m-85 -96.03 168.55 10.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.846 0.355 . . . . 0.0 110.897 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 4.7 p-80 -130.04 139.26 51.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.4 t70 -65.27 113.42 4.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 3.8 p -120.15 26.73 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.99 -10.79 3.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.509 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.474 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -43.8 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -108.04 31.83 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 25.0 m80 -148.3 120.14 8.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.741 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.55 169.83 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.505 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 11.2 m -106.49 -178.17 3.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -44.75 -44.16 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 39' ' ' GLY . . . -98.52 143.87 28.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -71.72 44.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.873 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 37' ' ' ALA . . . -149.75 -20.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -92.15 129.33 38.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.97 131.77 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.6 m -80.15 129.95 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 52.4 m -95.62 160.79 14.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.564 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 62.2 m -136.07 130.95 34.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.862 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.004 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.6 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.58 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.91 159.27 57.79 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.689 0.757 . . . . 0.0 110.964 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.77 79.79 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.66 2.24 . . . . 0.0 112.334 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.05 0.75 2.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.535 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 47.4 mt-30 -75.56 155.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 118.17 5.52 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.72 2.28 . . . . 0.0 112.344 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 104.55 2.67 43.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.669 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.0 t -134.59 154.65 51.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.812 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.724 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -165.99 -178.63 38.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -68.75 119.8 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 19.1 p -64.21 167.34 6.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.461 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER -155.08 149.89 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.666 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 57.8 mtt85 -41.39 146.31 0.55 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.596 0.712 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.997 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.3 Cg_endo -69.75 13.51 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.14 0 C-N-CA 122.711 -1.787 . . . . 0.0 112.329 0.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.666 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.5 m-20 -84.16 144.36 29.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 21.1 p90 -143.3 -177.19 5.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.944 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -87.2 132.65 33.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -147.76 116.6 6.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.47 -20.27 72.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.46 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -128.54 -158.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.738 0.304 . . . . 0.0 111.113 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -63.8 129.45 40.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.818 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 4.8 m -53.99 161.34 1.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.9 mt-10 -73.68 160.66 31.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -56.82 82.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 162.4 -37.6 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.859 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -95.97 179.54 5.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.897 0.379 . . . . 0.0 110.898 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.2 p-80 -137.71 131.42 31.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 10.7 t0 -60.47 114.25 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 43' ' ' CYS . 2.9 p -118.86 24.93 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.11 -11.54 3.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.447 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 47.6 t -44.85 -71.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.826 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 1.3 p30 -108.31 30.46 6.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.593 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 27.5 m80 -148.26 121.36 8.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.724 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.0 170.67 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.5 m -106.04 171.67 7.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -48.09 -39.84 21.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.99 124.3 37.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.9 p -59.59 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.43 -22.14 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -90.07 132.14 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.862 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.33 131.86 40.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.33 128.55 33.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 30.2 m -94.98 161.57 14.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 65.3 m -136.2 130.19 32.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.9 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.804 0.335 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.575 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.49 157.9 60.93 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.674 0.75 . . . . 0.0 110.929 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.5 Cg_endo -69.76 84.27 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.705 2.27 . . . . 0.0 112.336 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.76 11.94 3.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.532 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 18.3 mt-30 -75.93 155.12 84.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.59 0.71 . . . . 0.0 110.923 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 84.53 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.695 2.263 . . . . 0.0 112.342 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 135.26 3.05 2.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.665 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 2.3 t -134.45 152.28 51.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.721 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -164.81 -177.45 37.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -68.32 121.26 15.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.841 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.4 p -64.34 161.61 16.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -149.3 147.65 28.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.657 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 7.5 mtt180 -39.89 145.84 0.43 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.651 0.738 . . . . 0.0 110.87 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.024 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.9 Cg_endo -69.72 13.77 1.44 Allowed 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.695 -1.794 . . . . 0.0 112.314 -0.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.657 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -83.93 144.24 29.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.844 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.3 p90 -142.99 -172.31 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.464 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -92.42 135.14 34.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.904 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -146.46 104.15 3.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.45 78.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.427 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.56 -72.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.82 0.343 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.4 144.16 9.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 57.0 m -55.94 142.35 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.92 165.27 23.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.67 91.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.22 -24.04 3.12 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.854 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 62.2 m-85 -94.76 163.82 13.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.2 p-80 -127.46 141.97 51.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 1.9 t70 -64.94 114.96 4.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 19.1 p -126.73 22.22 6.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -57.89 -9.57 5.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.463 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -46.16 -67.09 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 -179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 33' ' ' HIS . 3.4 p30 -108.52 28.07 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 24.7 m80 -147.9 121.18 8.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.721 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.5 OUTLIER -118.68 168.23 10.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 7.8 m -103.85 168.11 9.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.889 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.97 -39.58 9.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.8 122.34 36.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.2 p -58.65 78.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.94 -22.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.2 m-20 -89.69 132.19 35.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.834 0.35 . . . . 0.0 110.818 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.9 134.7 37.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.3 m -80.44 128.55 33.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.3 m -102.69 136.6 42.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.589 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 37.1 m -111.71 134.43 53.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.024 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.129 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.824 0.345 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.576 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -85.01 158.61 58.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.671 0.748 . . . . 0.0 110.922 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.67 81.05 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.722 2.282 . . . . 0.0 112.358 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 2.06 2.74 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.52 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 43.7 mt-30 -75.98 155.2 84.75 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 118.67 5.82 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.708 2.272 . . . . 0.0 112.347 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 32' ' ' ASP . . . 102.73 3.18 49.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 4.3 t -134.16 155.55 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.729 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . -168.28 -177.59 39.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -68.66 121.38 16.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 18.9 p -64.15 165.39 9.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 2.9 t -154.43 149.27 26.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.654 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 3.1 mtt180 -40.95 146.04 0.51 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.637 0.732 . . . . 0.0 110.83 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.997 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.7 Cg_endo -69.77 13.41 1.52 Allowed 'Cis proline' 0 C--N 1.342 0.2 0 C-N-CA 122.643 -1.815 . . . . 0.0 112.339 -0.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.654 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.4 m-20 -84.15 145.7 28.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HE1' ' CD2' ' A' ' 26' ' ' PHE . 26.9 p90 -143.29 -177.12 5.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.3 136.39 32.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.871 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' CB ' ' SG ' ' A' ' 43' ' ' CYS . 1.7 tp10 -146.12 102.43 3.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.885 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.21 6.67 81.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.488 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.69 -76.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 111.127 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -158.14 144.5 17.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.849 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 25.8 m -65.02 158.81 24.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 25' ' ' GLY . 2.7 mm-40 -75.76 171.8 13.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.39 39.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 23' ' ' GLU . . . -162.08 10.6 0.11 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.463 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.883 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 3.6 m-85 -134.53 178.91 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.901 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.6 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 2.7 p-80 -138.02 129.29 27.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -57.84 115.02 2.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 4.5 p -119.0 23.45 11.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.04 -12.36 2.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -44.87 -70.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.514 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -108.82 30.82 6.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.834 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 30.9 m80 -148.08 120.63 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.729 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.6 OUTLIER -117.99 169.27 9.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 11.9 m -106.0 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.887 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 -39.64 8.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.854 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.68 121.39 35.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -58.05 78.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 168.75 -22.52 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 3.9 m-20 -88.82 131.05 35.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.32 130.54 40.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.5 m -80.38 131.91 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 61.3 m -96.11 161.4 13.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 73.7 m -136.56 129.8 31.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.559 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -84.87 155.04 61.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.658 0.742 . . . . 0.0 110.922 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.72 81.06 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.694 2.262 . . . . 0.0 112.352 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.67 13.19 2.08 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.508 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 19.0 mt-30 -75.59 156.07 85.15 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.615 0.721 . . . . 0.0 110.877 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 90.57 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.646 2.231 . . . . 0.0 112.39 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.78 -28.33 3.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.756 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 6.0 t -95.63 170.75 9.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.86 0.362 . . . . 0.0 110.933 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.698 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 175.88 -179.11 47.2 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.483 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.489 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -67.75 121.79 16.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.6 p -64.19 163.89 11.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.853 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 99.4 p -152.54 147.42 26.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.656 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 12.7 mmt-85 -39.76 145.57 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.632 0.73 . . . . 0.0 110.85 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 52.9 Cg_endo -69.82 13.68 1.5 Allowed 'Cis proline' 0 C--N 1.341 0.176 0 C-N-CA 122.688 -1.796 . . . . 0.0 112.285 0.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.656 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.21 145.05 28.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 22.2 p90 -143.32 -174.69 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.08 136.81 32.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.483 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 1.5 tp10 -146.88 114.84 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' CA ' ' OD1' ' A' ' 40' ' ' ASP . . . -101.03 6.11 56.49 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.518 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.63 -72.64 0.6 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.796 0.332 . . . . 0.0 111.087 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.8 145.91 12.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 60.3 m -57.02 143.86 36.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -70.56 165.69 22.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 m -57.53 92.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.5 -21.46 4.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.848 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 59.4 m-85 -95.02 162.79 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.851 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.556 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.7 p-80 -127.24 141.04 51.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 5.7 t0 -65.43 113.93 4.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 44' ' ' CYS . 7.3 p -121.81 24.55 9.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -55.08 -11.83 3.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.475 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.486 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 1.7 m -43.88 -71.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 110.862 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.572 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.5 OUTLIER -110.37 32.07 5.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 26.1 m80 -148.43 118.07 7.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.848 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.756 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -118.88 169.97 9.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.6 m -104.79 170.07 8.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.65 -38.96 22.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.67 123.84 37.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -59.62 77.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.06 -22.33 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.523 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.2 129.69 36.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.815 0.34 . . . . 0.0 110.888 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CD ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.51 133.61 37.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.88 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 18.0 m -79.74 130.14 35.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.0 m -103.46 136.13 43.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.556 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 39.5 m -110.79 134.24 52.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.1 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 5.0 p . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.489 ' HB2' ' CG ' ' A' ' 5' ' ' GLN . 0.6 OUTLIER -88.14 163.22 38.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.691 0.757 . . . . 0.0 110.906 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 34' ' ' TRP . 53.9 Cg_endo -69.79 102.64 1.06 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.224 . . . . 0.0 112.335 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 103.36 17.99 16.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.498 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.489 ' CG ' ' HB2' ' A' ' 2' ' ' TYR . 9.4 mt-30 -75.62 158.57 82.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.7 Cg_endo -69.76 90.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.239 . . . . 0.0 112.304 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.83 -25.8 5.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.467 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.757 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 5.4 t -95.55 169.47 10.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.906 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.704 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.06 -179.18 48.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.504 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.48 121.43 15.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 26.7 p -64.33 163.8 12.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 0.3 OUTLIER -150.82 146.75 26.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.664 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 6.9 mtp-105 -39.82 146.04 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.538 0.685 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.048 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.1 Cg_endo -69.75 13.98 1.42 Allowed 'Cis proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.732 -1.778 . . . . 0.0 112.319 0.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.664 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 1.3 m-20 -84.14 144.32 29.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 23.2 p90 -143.51 -173.18 3.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -91.49 135.53 33.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.829 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -146.81 105.76 3.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.88 4.77 75.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.445 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.8 -75.61 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.73 142.87 9.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 32.9 m -56.57 144.33 32.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.696 ' CG ' ' CD2' ' A' ' 26' ' ' PHE . 3.4 pt-20 -69.26 158.54 34.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.81 81.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 155.04 -24.94 0.61 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.475 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 3.1 m-85 -96.65 178.7 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.871 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.3 p-80 -137.48 134.25 35.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 7.7 t0 -62.41 116.65 5.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.3 p -122.23 27.27 8.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -54.83 -13.29 4.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -42.46 -73.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.887 0.375 . . . . 0.0 110.838 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.4 OUTLIER -110.46 33.18 4.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.878 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 26.7 m80 -148.62 117.27 6.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.757 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -118.83 171.87 7.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 9.4 m -105.31 169.77 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -48.45 -39.44 22.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -93.92 122.65 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.8 t -58.27 78.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 170.41 -22.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.46 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.483 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 5.9 m-20 -90.91 131.57 36.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 134.12 38.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 13.6 m -80.12 128.6 33.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 21.5 m -102.11 135.31 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.592 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 47.4 m -109.97 133.43 53.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.048 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 31' ' ' SER . 1.7 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.81 0.338 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.556 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -84.63 154.86 62.21 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.618 0.723 . . . . 0.0 110.934 -179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.7 80.8 0.84 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.69 2.26 . . . . 0.0 112.368 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.59 13.83 2.01 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 20.3 mt-30 -75.63 156.13 85.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.639 0.733 . . . . 0.0 110.896 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 5' ' ' GLN . 53.3 Cg_endo -69.79 91.56 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.307 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.06 -28.0 3.74 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.748 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 7.4 t -95.75 169.48 9.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.904 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.692 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 177.04 -179.39 47.98 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -68.35 121.86 17.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 20.8 p -63.91 168.26 5.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.928 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 35.8 t -153.99 147.36 24.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.677 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 1.7 mmt-85 -39.88 146.31 0.4 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.878 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.081 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 53.8 Cg_endo -69.76 14.11 1.41 Allowed 'Cis proline' 0 C--N 1.341 0.15 0 C-N-CA 122.656 -1.81 . . . . 0.0 112.346 0.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.677 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -85.0 143.85 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.858 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 18.8 p90 -143.31 -173.67 4.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.596 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.45 131.84 35.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.2 tp10 -147.06 116.04 6.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.59 -16.54 75.39 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.452 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -127.64 -160.92 1.04 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 111.094 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -64.29 130.97 45.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.7 m -54.17 159.8 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 25' ' ' GLY . 4.4 mt-10 -72.63 158.87 34.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -56.58 80.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 161.32 -32.85 0.37 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE1' ' HB2' ' A' ' 45' ' ' ALA . 2.4 m-85 -95.69 178.37 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.858 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.605 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.7 p-80 -137.22 130.44 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 3.1 t0 -61.84 114.23 3.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.6 p -118.09 27.38 9.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.88 -13.87 3.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.477 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 35.7 p -42.19 -74.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 1.3 p-10 -110.05 32.96 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 32' ' ' ASP . 27.6 m80 -148.2 116.69 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.748 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -117.65 172.27 7.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' HB2' ' CB ' ' A' ' 40' ' ' ASP . 8.2 m -105.77 170.98 7.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.65 -39.5 24.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.17 123.37 37.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.128 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.9 p -58.89 79.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.55 -22.64 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.441 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -90.92 132.73 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.792 0.33 . . . . 0.0 110.864 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.06 133.13 42.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 m -80.4 126.85 31.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 18.0 m -99.48 136.23 39.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.605 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 49.6 m -109.89 132.23 54.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.081 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' SER . 24.1 p . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.599 ' CG ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -124.27 158.16 62.01 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.753 0.787 . . . . 0.0 110.898 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 2' ' ' TYR . 53.9 Cg_endo -69.69 79.31 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.737 2.291 . . . . 0.0 112.367 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.31 2.59 2.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' A' ' 2' ' ' TYR . 54.9 mt-30 -75.29 155.49 85.95 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.634 0.731 . . . . 0.0 110.919 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 82.57 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.398 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.7 -29.57 1.86 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.456 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.626 ' SG ' ' CD1' ' A' ' 34' ' ' TRP . 1.8 t -96.1 158.54 15.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' HA2' ' CZ2' ' A' ' 34' ' ' TRP . . . 178.14 -176.32 47.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -69.08 122.28 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.872 0.367 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 33' ' ' HIS . 25.9 p -63.54 166.73 6.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.482 ' O ' ' CG ' ' A' ' 15' ' ' ASN . 33.8 m -151.98 147.58 26.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.672 ' HA ' ' N ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -39.68 146.24 0.39 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.611 0.72 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.083 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 54.0 Cg_endo -69.77 14.09 1.42 Allowed 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.635 -1.819 . . . . 0.0 112.38 -0.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.672 ' N ' ' HA ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -85.18 143.94 28.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.602 ' CD2' ' O ' ' A' ' 17' ' ' CYS . 17.9 p90 -143.5 -173.83 4.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.602 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 1.3 m -89.43 131.36 35.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.963 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' ARG . 2.3 tp10 -146.75 116.01 7.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.51 -13.15 80.79 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.478 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 18' ' ' GLU . . . -130.57 -160.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -64.35 130.26 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.826 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 28' ' ' ASP . 3.4 m -54.61 159.81 2.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER -71.98 157.91 36.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.1 m -55.6 82.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 23' ' ' GLU . . . 158.19 -32.96 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.468 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.919 ' CE2' ' HB2' ' A' ' 45' ' ' ALA . 2.3 m-85 -95.12 177.43 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 44' ' ' CYS . 3.5 p-80 -136.67 131.16 33.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' N ' ' SG ' ' A' ' 22' ' ' CYS . 2.1 t70 -63.01 110.9 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.866 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 42' ' ' CYS . 6.1 p -114.02 26.3 10.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 33' ' ' HIS . . . -53.43 -13.81 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.51 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.444 ' O ' ' SG ' ' A' ' 1' ' ' CYS . 21.4 m -43.11 -74.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 110.838 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 0.5 OUTLIER -107.81 31.37 5.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.841 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 11' ' ' CYS . 29.5 m80 -146.94 116.42 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' CZ2' ' HA2' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -117.65 166.59 12.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 10.3 m -101.23 173.15 6.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.7 -39.55 51.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 39' ' ' GLY . . . -94.03 122.76 36.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.087 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.4 m -58.42 79.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 169.31 -22.8 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.504 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 12.9 m-20 -89.94 131.21 35.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.788 0.328 . . . . 0.0 110.874 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -95.85 132.74 40.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 1.8 m -79.59 127.39 32.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 19.6 m -101.14 134.43 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.603 ' O ' ' CD2' ' A' ' 27' ' ' HIS . 50.2 m -108.82 132.54 53.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 1.083 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.128 179.855 . . . . . . . . 1 1 . 1 stop_ save_